|
|
||||||||
J Thorac Cardiovasc Surg 1994;107:1203-1209
© 1994 Mosby, Inc.
CARDIOPULMONARY BYPASS, |
Vancouver, B.C., Canada
Supported by the Rick Hansen Man in Motion Legacy Fund.
Received for publication March 25, 1993. Accepted for publication Aug. 19, 1993. Address for reprints: A. K. Qayumi, MD, PhD, Assistant Professor of Surgery, Department of Surgery, Room 3100910 W. 10 Ave., Vancouver, British Columbia, V5Z 4E3.
Abstract
Fourteen domestic swine were divided into two groups. Group A (n= 7) was the control group, in which no pharmacologic intervention was applied. In group B (n= 7), the ischemic-reperfused spinal cord was treated with the combination of allopurinol (50 mg/kg/day for 3 days before the day of operation) and deferoxamine (Desferal, 50 mg/kg administered intravenously over 3 to 4 hours). The administration of deferoxamine was completed 1 hour before crossclamping. The crossclamp was placed on the descending aorta just distal to the left subclavian artery for 30 minutes. Proximal hypertension was controlled with sodium nitroprusside and volume depletion. Methods of assessment included an evaluation of the neurologic status of the animals by quantitative Tarlov criteria, blood flow by radiolabeled microspheres, and histologic examination of the spinal cord. All animals in the control group, group A, were completely paraplegic with 0% recovery by Tarlov criteria at 24 hours after the removal of the crossclamp. In contrast, all animals in group B, in which the combination of allopurinol and deferoxamine was used, completely recovered (100% recovery by Tarlov criteria), and at 24 hours after the ischemic episode they were able to walk with no difficulty and had intact sensation. Functional parameters of these animals fully correlated with the morphologic findings. Widespread acute neuronal injury and vacuolation of neuropil were observed in the control group of animals. In contrast, animals in group B showed much less pronounced morphologic changes after the same period of ischemia. In summary, the combined use of these agents significantly (p< 0.001) reduced the incidence of paraplegia induced by aortic crossclamping with 82% additivity. (J THORAC CARDIOVASC SURG1994;107:1203-9)
This article has been cited by other articles:
![]() |
I. K. Toumpoulis, J. C. Papakostas, M. I. Matsagas, V. D. Malamou-Mitsi, L. S. Pappa, G. E. Drossos, J. J. DeRose, and C. E. Anagnostopoulos Superiority of early relative to late ischemic preconditioning in spinal cord protection after descending thoracic aortic occlusion J. Thorac. Cardiovasc. Surg., November 1, 2004; 128(5): 724 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kuniyoshi, K. Koja, K. Miyagi, M. Shimoji, T. Uezu, K. Arakaki, S. Yamashiro, K. Mabuni, S. Senaha, and Y. Nakasone Prevention of postoperative paraplegia during thoracoabdominal aortic surgery Ann. Thorac. Surg., November 1, 2003; 76(5): 1477 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rahman, B. Ustundag, O. Burma, I. H. Ozercan, and F. S. Erol Neuroprotective effect of regional carnitine on spinal cord ischemia-reperfusion injury Eur. J. Cardiothorac. Surg., July 1, 2001; 20(1): 65 - 70. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |